Last reviewed · How we verify

NCT05902897

Aortic or Mitral Valve Replacement With the Braile Biomédica® Bovine Pericardium Valvular Bioprosthesis

Completed Last updated 25 April 2025
What this trial tests

trial testing Braile Biomédica® Bovine Pericardium Valvular Bioprosthesis. in Aortic Valve Insufficiency in 913 participants. Completed in 30 October 2023.

Timeline
1 January 2023
Primary endpoint
1 July 2023
30 October 2023

Quick facts

Lead sponsorBraile Biomedica Ind. Com. e Repr. Ltda.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment913
Start date1 January 2023
Primary completion1 July 2023
Estimated completion30 October 2023
Sites3 locations across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Braile Biomedica Ind. Com. e Repr. Ltda.

Who can join

18 and older, any sex, with Aortic Valve Insufficiency or Aortic Valve Regurgitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Collect data on the safety and clinical performance of the Braile Biomédica® Bovine Pericardium Valvular Bioprosthesis

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aortic Valve Insufficiency

Currently open trials in the same condition.

Other Braile Biomedica Ind. Com. e Repr. Ltda. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05902897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing